Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
Prevalence of hepatitis c virus infection among patients with COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
Features the effectiveness of the treatment of moxifloxacin in patients with co-infections tuberculosis/HIV and hepatitis B,and/or C Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005
The incidence of hepatitis C virus in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006
The clinical flow and efficiency of treatment of pulmonary tuberculosis in patients with chorine organic pasticides and viral hepatitis ‘B‘ markers Source: Eur Respir J 2004; 24: Suppl. 48, 50s Year: 2004
Sarcoidosis associated with interferon-α therapy for chronic hepatitis C Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006
Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
The risk of hepatotoxicity of anti-tuberculosis drugs in patients from regions with high prevalence of hepatitis B Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
The frequency of respiratory infections in patients with chronic hepatitis C treated with pegylated-Interferon Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C Source: Eur Respir J 2005; 26: Suppl. 49, 84s Year: 2005
Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 13s Year: 2006
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Introduction of a Latent TB infection (LTBI) screening programme detects cases of active tuberculosis and hepatitis B and C Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
The psychological type of chronic pulmonary TB patients Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001
Vitamin C levels in Indian patients with active pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002